---
title: "TDOC.US (TDOC.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TDOC.US/news.md"
symbol: "TDOC.US"
name: "TDOC.US"
parent: "https://longbridge.com/en/quote/TDOC.US.md"
datetime: "2026-05-20T03:21:25.590Z"
locales:
  - [en](https://longbridge.com/en/quote/TDOC.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TDOC.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TDOC.US/news.md)
---

# TDOC.US (TDOC.US) — Related News

### [Teladoc Health Target of Unusually Large Options Trading (NYSE:TDOC)](https://longbridge.com/en/news/286944473.md)
*2026-05-19T16:20:55.000Z*
> Teladoc Health (NYSE:TDOC) experienced unusual options trading with 26,725 call options purchased, an 81% increase from 

### [Teladoc (TDOC) Gets a Hold from UBS](https://longbridge.com/en/news/286568783.md)
*2026-05-15T12:41:15.000Z*
> UBS analyst Kevin Caliendo has maintained a Hold rating on Teladoc (TDOC) with a price target of $6.00. Caliendo, a 4-st

### [Teladoc Health extends rally to seventh straight session, gaining 22%](https://longbridge.com/en/news/285764179.md)
*2026-05-08T18:51:18.000Z*
> Shares of Teladoc Health (TDOC) rose over 4% on Friday, marking a seven-session winning streak and a total gain of appro

### [Teladoc Hold Rating Reaffirmed as 2026 Outlook Tightens and $6 DCF-Based Price Target Remains Unchanged](https://longbridge.com/en/news/285015852.md)
*2026-05-04T01:45:23.000Z*
> TD Cowen analyst Charles Rhyee has reaffirmed a Hold rating on Teladoc (TDOC) stock, citing tightened 2026 guidance for 

### [Teladoc Health Q1 Earnings Call Highlights](https://longbridge.com/en/news/284970539.md)
*2026-05-02T14:27:03.000Z*
> Teladoc Health (NYSE:TDOC) reported Q1 2026 results with revenue of $614M and Adjusted EBITDA of $58M, exceeding guidanc

### [Teladoc Health Q1 Loss Reduction Reinforces Bullish Margin Narrative Despite Flat Revenue](https://longbridge.com/en/news/284883609.md)
*2026-05-01T10:10:33.000Z*
> Teladoc Health reported Q1 2026 revenue of $613.8 million with a basic EPS loss of $0.36, showing a slight decline from 

### [Unchanged Risk Disclosures at Teladoc Raise Questions About Emerging Threats and Investor Exposure](https://longbridge.com/en/news/284869781.md)
*2026-05-01T06:01:50.000Z*
> Teladoc Inc. (TDOC) has maintained its risk disclosures in its latest Form 10-Q, indicating no material updates from its

### [Teladoc Shares Fall After Q1 Earnings: What Investors Need To know](https://longbridge.com/en/news/284644708.md)
*2026-04-29T20:57:06.000Z*
> Teladoc Health (NYSE:TDOC) shares fell 5.6% to $5.62 after reporting mixed Q1 earnings. Revenue was $613.8 million, down

### [Teladoc | 8-K: FY2026 Q1 Revenue Beats Estimate at USD 613.85 M](https://longbridge.com/en/news/284691188.md)
*2026-04-30T04:12:43.000Z*
### [Earnings Snapshot: Teladoc Health issues weak Q2 revenue outlook after mixed Q1 results](https://longbridge.com/en/news/284689977.md)
*2026-04-30T04:02:20.000Z*
> Earnings Snapshot: Teladoc Health issues weak Q2 revenue outlook after mixed Q1 results